Caner Saygin, Assistant Professor of Medicine at Division of the Biological Sciences at The University of Chicago, shared a post on X:
“Proud of the science that our lab will present at ASH24 this weekend:
- Targeting menin in T-ALL: Kate Shimamoto
- CH in pediatric ALL survivors: Habib El-Khoury, Ella Postich
- Evolution of CH on vs off lenalidomide: Jen Cooperrider, Diren Arda Karaoglu
- TP53m ALL: Ethan Harris
